Articles from Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Micot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026

By Shaanxi Micot Pharmaceutical Technology Co., Ltd. · Via ACN Newswire · August 7, 2026